Abstract
Hemophilia A is a sex-linked recessive hereditary disease that is relatively rare and the number of patients with this disorder who undergo major surgery is limited. Although replenishing coagulation factors can allow hemophiliac patients to undergo similar surgery to that performed for patients without hemophilia, there have been few reports on major surgery and none on the resection of lung cancer in patients with hemophilia A. We recently performed completion pneumonectomy of the left lung in a 70-year-old man with hemophilia A, for squamous cell carcinoma in the residual left lung. The administration of a recombinant DNA coagulation factor VIII preparation allowed this operation to be successfully carried out. This case serves to demonstrate that the recombinant DNA coagulation factor VIII preparation described may enable us to safely perform major surgery on hemophiliac patients, since there is no risk of viral infection or any other adverse effects, such as deterioration of immunocompetence or hemolysis, which are occasionally encountered with human plasma-derived preparations.
Similar content being viewed by others
References
Rudowski WJ, Scharf R, Ziemski JM (1987) Is major surgery in hemophiliac patients safe? World J Surg 11:378–386
Ogawa M, Nishiguchi Y, Yamashita T, Yanagawa K, Sowa M, Hiyoshi M (1997) A patient with hemophilia A in whom total gastrectomy was performed using recombinant factor VIII. Jpn J Gastroenterol Surg 30:102–106
Tomeoku M, Kuto M, Tsuda M, Nagano M, Wada H, Murashima S, Ito T, Deguchi K, Shirakawa S (1983) Clinical studies on surgeries in 7 hemophiliacs. Rinsho Ketsueki 24:232–241
Onda M, Urazumi K, Abe R, Matsuo K (1998) Obstructive ileus caused by blood clot after emergency total gastrectomy in a patient with hemophilia A: report of a case. Surg Today 28:1266–1269
Schwartz RS, Abildgaard CF, Aledort LM, Arkin S, Bloom AL, Brackmann HH, Brettler DB, Fukui H, Hilgartner MW, Inwood MJ, Kasper CK, Kernoff PBA, Levine PH, Lusher JM, Mannucci PM, Scharrer I, MacKenzie MA, Pancham N, Kuo HS, Allred RU (1990) Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. Recombinant factor VIII study group. N Engl J Med 323:1800–1805
Fukutake K, Kagawa K, Koshihara K, Arai M, Yorifuji H, Fujimaki M (1991) Characterization of recombinant human factor VIII (BAY w 6240) and effect of von Willebrand factor on determination of factor VIII activity. Jpn Pharmacol Ther 19:891–897
Schroeder W, Kato M, Horvath K, Sawada S, Hironaka T (1991) Structure and composition of recombinant human factor VIII produced in baby hamster kidney cells. Jpn Pharmacol Ther 19:2207–2220
Fukui H, Yoshioka A, Shima M, Tanaka I, Koshihara K, Fukutake K, Fujimaki M (1991) Clinical evaluation of recombinant human factor VIII (BAY w 6240) in the treatment of hemophilia A. Int J Hematol 54:419–427
Amaral JF (1994) The experimental development of an ultrasonically activated scalpel for laparoscopic use. Surg Laparosc Endosc 4:92–99
Baggish MS, Tucker RD (1995) Tissue actions of bipolar scissors compared with monopolar devices. Fertil Steril 63:422–426
Go PM, Goodman GR, Bruhn EW, Hunter JG (1991) The argon beam coagulator provides rapid hemostasis of experimental hepatic and splenic hemorrhage in anticoagulated dogs. J Trauma 31:1294–1300
Wadhwa M, Dilger P, Tubbs J, Mire-Sluis A, Barrowcliffe T, Thorpe R (1994) Identification of transforming growth factorbeta as a contaminant in factor VIII concentrates: a possible link with immunosuppressive effects in hemophiliacs. Blood 84:2021–2030
Seeler RA (1972) Hemolysis due to anti-A and anti-B in factor VIII preparations. Arch Intern Med 130:101–103
Mannucci PM, Brettler DB, Aledort LM, Lusher JM, Abildgaard CF, Schwartz RS, Hurst D (1994) Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. Blood 83:1958–1962
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nomoto, Y., Kimura, H., Iwai, N. et al. Completion pneumonectomy of the residual left lung to treat lung cancer in a patient with hemophilia a: Report of a case. Surg Today 30, 917–920 (2000). https://doi.org/10.1007/s005950070045
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s005950070045